Cargando…
Muscle wasting in myotonic dystrophies: a model of premature aging
Myotonic dystrophy type 1 (DM1 or Steinert’s disease) and type 2 (DM2) are multisystem disorders of genetic origin. Progressive muscular weakness, atrophy and myotonia are the most prominent neuromuscular features of these diseases, while other clinical manifestations such as cardiomyopathy, insulin...
Autores principales: | Mateos-Aierdi, Alba Judith, Goicoechea, Maria, Aiastui, Ana, Fernández-Torrón, Roberto, Garcia-Puga, Mikel, Matheu, Ander, López de Munain, Adolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496580/ https://www.ncbi.nlm.nih.gov/pubmed/26217220 http://dx.doi.org/10.3389/fnagi.2015.00125 |
Ejemplares similares
-
Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin
por: García-Puga, Mikel, et al.
Publicado: (2020) -
Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022) -
Senescence plays a role in myotonic dystrophy type 1
por: García-Puga, Mikel, et al.
Publicado: (2022) -
Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
por: Wang, Youjin, et al.
Publicado: (2019) -
Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1)
por: Alegre-Cortés, Eva, et al.
Publicado: (2022)